Industry: Medical Technologies
Reference Market: IT, UK
Inflow: MI2020 London2018
Total capital raised so far: £1,5M
Key person infos
Nome Cognome: Nicolò Briante
D-Heart is the first smartphone ECG device that simple to use, clinically reliable, portable and affordable. It allows anyone to perform a hospital-level ECG in total autonomy and to send the results to the 24/7 tele-cardiology service or to your trusted doctor.
We have started the sales from April 2018 after we achieved the ISO 13485/9001 and the CE mark as class IIA device for Homecare use and now we are 510k FDA pending. The device is manufactured in Italy and this year we won the Red Dot Design Award as the best medical design product. We sold 550 units and we appointed exclusive distributors in 3 countries: Brazil; Cyprus and Greece; South Africa and we are under negotiation for additional distribution agreements in 6 countries.